| Terpenoids and a Flavonoid Glycoside from Acacia pennata Leaves as Hedgehog/GLI-Mediated Transcriptional Inhibitors Y Rifai, MA Arai, T Koyano, T Kowithayakorn, M Ishibashi Journal of natural products 73 (5), 995-997, 2010 | 87 | 2010 |
| New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha Y Rifai, MA Arai, SK Sadhu, F Ahmed, M Ishibashi Bioorganic & medicinal chemistry letters 21 (2), 718-722, 2011 | 66 | 2011 |
| The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse model Y Rifai, ASF Elder, CJ Carati, DJ Hussey, X Li, CM Woods, AC Schloithe, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 294 (4 …, 2008 | 31 | 2008 |
| Acoschimperoside P, 2′-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra Y Rifai, MA Arai, T Koyano, T Kowithayakorn, M Ishibashi Journal of natural medicines 65, 629-632, 2011 | 27 | 2011 |
| Short route to cassane-type diterpenoids: synthesis of the supposed structure of benthaminin 1 S Mahdjour, M Harche-Kaid, A Haidour, R Chahboun, ... Organic letters 18 (22), 5964-5967, 2016 | 26 | 2016 |
| A Bisindole Alkaloid with Hedgehog Signal Inhibitory Activity from the Myxomycete Perichaena chrysosperma A Shintani, K Toume, Y Rifai, MA Arai, M Ishibashi Journal of natural products 73 (10), 1711-1713, 2010 | 25 | 2010 |
| Three New Glycosides from the Stems of Miliusa balansae Y Lei, LJ Wu, HM Shi, PF Tu Helvetica Chimica Acta 91 (3), 495-500, 2008 | 20 | 2008 |
| Docking Molekuler Senyawa 5, 5’-Dibromometilsesamin AA Pratama, Y Rifai, A Marzuki Majalah Farmasi dan Farmakologi 21 (3), 67-69, 2017 | 19 | 2017 |
| Application of the Intramolecular Diels–Alder Vinylarenе (IMDAV) Approach for the Synthesis of Thieno [2, 3-f] isoindoles MA Nadirova, YOV Laba, VP Zaytsev, JS Sokolova, KM Pokazeev, ... Synthesis 52 (15), 2196-2223, 2020 | 13 | 2020 |
| Molecular modeling and phenoloxidase inhibitory activity of arbutin and arbutin undecylenic acid ester A Masyita, E Salim, RM Asri, F Nainu, A Hori, R Yulianty, M Hatta, Y Rifai, ... Biochemical and Biophysical Research Communications 547, 75-81, 2021 | 11 | 2021 |
| Synthesis, Molecular Mechanism and Pharmacokinetic Studies of New Epoxy Lignan‐Based Derivatives Y Rifai, HB Tani, M Nur, M Aswad, S Lallo, E Wahyudin Archiv der Pharmazie 349 (11), 848-852, 2016 | 9 | 2016 |
| The characterization and anti-osteoporotic activity of Sappan Lignum (Caesalpinia sappan L.) extracts S Subehan, Y Rifai International journal of phytomedicine 5 (1), 07, 2013 | 9 | 2013 |
| Curcumin Content in extract of some Rhizomes from Zingiberaceae Family RR Yustinianus, J Wunas, Y Rifai, N Ramli Journal of Pharmaceutical and Medicinal Sciences 4 (1), 2020 | 8 | 2020 |
| The ability of Abelmoschus manihot L. leaf extract in scavenging of free radical DPPH and total flavonoid determination S Sudewi, WA Lolo, M Warongan, Y Rifai, H Rante IOP Conference Series: Materials Science and Engineering 259 (1), 012020, 2017 | 8 | 2017 |
| Molecular docking studies of arbutin derivatives as tyrosinase inhibitors A Masyita, Y Rifai Int J Biosci Biochem Bioinforma 9 (3), 188-193, 2019 | 7 | 2019 |
| Formulation and Characterization of Self Nano-Emulsifying Drug Delivery System (SNEDDS) Fraction of N-Hexane: Ethyl Acetate from Sesewanua Leaf (Clerodendrum Fragrans Wild.) Z Sapiun, AK Imran, STR Dewi, DFM Pade, W Ibrahim, R Tungadi, ... International Journal of Applied Pharmaceutics 15 (2), 72-77, 2023 | 6 | 2023 |
| Excoecaria agallocha Linn (Euphrobiaceae): An overview K Rajeswari, T Bhaskara-Rao J. Chem. Pharm. Res 7 (10), 423-439, 2015 | 6 | 2015 |
| Anthocyanin-rich buni-berry (Antidesma bunius) extract increases paraoxonase 1 gene expression in BALB/c mice fed with a high-fat diet S Tawali, S As’ad, M Hatta, A Bukhari, N Khairi, Y Rifai, R Dwiyanti Journal of Young Pharmacists 11 (1), 46, 2019 | 5 | 2019 |
| Characterization and stability evaluation of nanoencapsulated epoxylignans Y Rifai, R Riski, G Alam, M Litaay, L Rahman F1000Research 7, 2018 | 5 | 2018 |
| Molecular docking of phytochemical compounds of Momordica charantia as potential inhibitors against SARS-CoV-2 YM Evary, A Masyita, AA Kurnianto, RM Asri, Y Rifai Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2022 | 4 | 2022 |
